{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:47:23Z","timestamp":1772160443289,"version":"3.50.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T00:00:00Z","timestamp":1258502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T00:00:00Z","timestamp":1258502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1111\/j.1365-2133.2009.09590.x","type":"journal-article","created":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T06:18:38Z","timestamp":1258525118000},"page":"790-797","source":"Crossref","is-referenced-by-count":23,"title":["Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus"],"prefix":"10.1093","volume":"162","author":[{"given":"M.","family":"Saha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A-M.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bhogal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.W.","family":"Groves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,11,18]]},"reference":[{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1001\/archderm.1992.04530010064010","article-title":"Treatment of pemphigus vulgaris with pulse intravenous cyclophosphamide","volume":"128","author":"Pandya","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/archderm.1976.01630310024005","article-title":"Pemphigus: a 20-year review of 107 patients treated with corticosteroids","volume":"112","author":"Rosenberg","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1365-2133.2003.05665.x","article-title":"Guidelines for the management of pemphigus vulgaris","volume":"149","author":"Harman","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.4049\/jimmunol.128.6.2453","article-title":"Suppression of human B lymphocyte function by cyclophosphamide","volume":"128","author":"Cupps","year":"1982","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/archderm.1997.03890380101016","article-title":"Pulse intravenous cyclophosphamide for treatment of autoimmune blistering disease. Is there an advantage over oral routes?","volume":"133","author":"Werth","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1056\/NEJM198402163100710","article-title":"Cyclophosphamide: should it be used daily, monthly, or never?","volume":"310","author":"Steinberg","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0733-8635(05)70194-7","article-title":"Pulse intravenous cyclophosphamide therapy for dermatologic disorders","volume":"18","author":"Fox","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1365-4362.1995.tb04430.x","article-title":"Dexamethasone-cyclophosphamide pulse therapy for pemphigus","volume":"34","author":"Pasricha","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D35JR0R66P","article-title":"Dexamethasone-cyclophosphamide pulse therapy for autoimmune-vesiculobullous disorders at Victoria Hospital, Bangalore","volume":"9","author":"Sacchidanand","year":"2003","journal-title":"Dermatol Online J"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-4362.1990.tb04767.x","article-title":"Dexamethasone-cyclophosphamide pulse therapy in pemphigus","volume":"29","author":"Kaur","year":"1990","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000057886","article-title":"Long-term efficacy of dexamethasone-cyclophosphamide pulse therapy in pemphigus","volume":"204","author":"Kanwar","year":"2002","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archderm.135.1.57","article-title":"Pulse intravenous cyclophosphamide therapy in pemphigus","volume":"135","author":"Fleischli","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/1120009X.1992.11739140","article-title":"Cyclophosphamide plus vincristine and prednisone in the treatment of severe pemphigus vulgaris refractory to conventional therapy","volume":"4","author":"Citarrella","year":"1992","journal-title":"J Chemother"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","article-title":"Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris","volume":"57","author":"Chams-Davatchi","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1610-0378.2005.04747.x","article-title":"Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study","volume":"3","author":"Rose","year":"2005","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2133.2001.04132.x","article-title":"The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels","volume":"144","author":"Harman","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1365-2230.2000.00624.x","article-title":"Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3","volume":"25","author":"Harman","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0190-9622(84)80193-0","article-title":"Cyclophosphamide (Cytoxan). A review on relevant pharmacology and clinical uses","volume":"11","author":"Ahmed","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB19|cit19","first-page":"906","article-title":"Intravenous pulse cyclophosphamide treatment for SLE and the risk of malignancy","volume":"38","author":"Mayes","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1002\/art.20583","article-title":"Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action","volume":"50","author":"Buttgereit","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB21|cit21","first-page":"9","article-title":"Monthly intravenous pulse cyclophosphamide therapy in Wegener\u2019s granulomatosis","volume":"14","author":"Le Thi","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D36NS4V35J","article-title":"Cyclophosphamide pulses with oral prednisolone in the treatment of pemphigus: a pilot study","volume":"11","author":"Bhat","year":"2005","journal-title":"Dermatol Online J"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB23|cit23","first-page":"101","article-title":"Treatment of cicatricial pemphigoid with pulse intravenous cyclophosphamide","volume":"137","author":"Musette","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198603063141004","article-title":"Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs","volume":"314","author":"Austin","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1067\/mjd.2000.110397","article-title":"Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris","volume":"43","author":"Hayag","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1046\/j.1365-4362.2002.01407.x","article-title":"Immunoablative high-dose cyclophosphamide without stem cell rescue in pemphigus foliaceus","volume":"41","author":"Cohen","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1365-4632.2005.02218.x","article-title":"Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases","volume":"44","author":"Mahajan","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1468-3083.2006.01540.x","article-title":"The role of IVIg treatment in severe pemphigus vulgaris","volume":"20","author":"Baum","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/08916930600972040","article-title":"Immunoadsorption in pemphigus","volume":"39","author":"Eming","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1111\/j.1365-2133.2009.09590.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jaad.2004.06.007","article-title":"Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab)","volume":"51","author":"Morrison","year":"2004","journal-title":"J Am Acad Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2009.09590.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2009.09590.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2009.09590.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T11:56:56Z","timestamp":1685188616000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/162\/4\/790\/6642447"}},"subtitle":["PPC therapy in refractory pemphigus"],"short-title":[],"issued":{"date-parts":[[2009,11,18]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09590.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1287956.755054","asserted-by":"object"}]},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11,18]]}}}